Skip to main content

Table 4 Comorbidities of patients with IPF according to their smoking habits

From: Effect of smoking and comorbidities on survival in idiopathic pulmonary fibrosis

 

Non-smokers

Ex-smokers

Current smokers

p-value

Cardiovascular diseases a

34 (75.6)

46 (69.7)

12 (70.6)

0.790

Coronary artery disease

22 (48.9)

29 (43.9)

10 (58.8)

0.537

Hypertension

23 (51.1)

28 (42.4)

6 (35.3)

0.474

Cerebral infarction

3 (6.7)

8 (12.1)

2 (11.8)

0.629

TIA

3 (6.7)

5 (7.6)

 

0.511

Diabetes

13 (28.9)

18 (27.3)

1 (6.3)

0.145

Heart failure b

16 (35.6)

14 (21.2)

3 (17.6)

0.169

Asthma

7 (15.6)

9 (13.6)

4 (23.5)

0.605

Depression

4 (8.9)

4 (6.1)

1 (6.3)

0.832

GER

3 (6.7)

10 (15.2)

1 (6.3)

0.288

Lung cancer

 

4 (6.1)

5 (29.4)

<0.001

COPD

 

3 (4.5)

7 (41.2)

<0.001

OSA

2 (4.4)

3 (4.5)

1 (6.3)

0.969

  1. N number, NS p-value > 0.05, TIA transient ischemic attack, GER gastro-esophageal reflux, COPD chronic obstructive pulmonary disease, OSA obstructive sleep apnea
  2. aCoronary artery disease, cerebral infarction and hypertension
  3. bHeart failure for any reason